Intravesical BCG treatment is inversely associated with the risk of developing Alzheimer's Disease or other dementia among non-muscle-invasive bladder cancer patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravesical BCG treatment is inversely associated with the risk of developing Alzheimer's Disease or other dementia among non-muscle-invasive bladder cancer patients
Authors
Keywords
Aging, BCG, Dementia, Immunotherapy, Intravesical Therapy
Journal
Clinical Genitourinary Cancer
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-05-17
DOI
10.1016/j.clgc.2021.05.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease
- (2020) David Gate et al. NATURE
- Can immunization with Bacillus Calmette-Guérin (BCG) protect against Alzheimer’s disease?
- (2019) Ofer N. Gofrit et al. MEDICAL HYPOTHESES
- Bacillus Calmette-Guérin (BCG) therapy lowers the incidence of Alzheimer’s disease in bladder cancer patients
- (2019) Ofer N. Gofrit et al. PLoS One
- Epidemiological and Economic Burden of Alzheimer's Disease: A Systematic Literature Review of Data across Europe and the United States of America
- (2018) Claire Takizawa et al. JOURNAL OF ALZHEIMERS DISEASE
- BCG Therapy for Type 1 Diabetes: Restoration of Balanced Immunity and Metabolism
- (2018) Willem M. Kühtreiber et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Challenges and Considerations Related to Studying Dementia in Blacks/African Americans
- (2017) Eseosa T. Ighodaro et al. JOURNAL OF ALZHEIMERS DISEASE
- Immunization with Bacillus Calmette-Guérin (BCG) alleviates neuroinflammation and cognitive deficits in APP/PS1 mice via the recruitment of inflammation-resolving monocytes to the brain
- (2017) Zejie Zuo et al. NEUROBIOLOGY OF DISEASE
- Bacillus Calmette-Guérin Confers Neuroprotection in a Murine Model of Japanese Encephalitis
- (2016) Sahil Kulkarni et al. NEUROIMMUNOMODULATION
- Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer’s disease model
- (2016) Hyunjung Baek et al. Oncotarget
- Immune attack: the role of inflammation in Alzheimer disease
- (2015) Frank L. Heppner et al. NATURE REVIEWS NEUROSCIENCE
- Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer’s disease pathology
- (2015) Kuti Baruch et al. Nature Communications
- The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive Impairment
- (2013) R. Tarawneh et al. Cold Spring Harbor Perspectives in Medicine
- Management of patients with Alzheimer’s disease: pharmacological treatment and quality of life
- (2012) Enrico Mossello et al. Therapeutic Advances in Chronic Disease
- Democratizing Information Creation From Health Care Data for Quality Improvement, Research, and Education—The Montefiore Medical Center Experience
- (2010) Eran Bellin et al. ACADEMIC MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now